Labshake search
Citations for R&D Systems :
1 - 50 of 3295 citations for ADAM Metallopeptidase With Thrombospondin Type 1 Motif 9 ADAMTS9 Antibody since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2019Quote: ... the secretion levels of Matrix metallopeptidase (MMP)-2 and -9 (R&D system, MN, USA) and transforming growth factor (TGF)-β1 (R&D system ...
-
bioRxiv - Cell Biology 2022Quote: ... we added recombinant thrombospondin-1 (R&D Systems) at the indicated concentrations 24 hours post isolation and cultured the cells for a total of 6 days ...
-
bioRxiv - Molecular Biology 2023Quote: ... anti-Thrombospondin-4 (cat# AF2390; R&D Systems), and anti-TIMP-1 (cat# AF980 ...
-
bioRxiv - Cell Biology 2023Quote: ... anti-Thrombospondin-4 (cat# AF2390; R&D Systems), anti-TGF-β3 (cat# ab15537 ...
-
bioRxiv - Biophysics 2023Quote: ... The samples were then exposed to either 10 nM thrombospondin-1 (TSP-1) (3074-TH, R&D Systems) or HBSS for 10 min at 37°C ...
-
bioRxiv - Cell Biology 2021Quote: TSP1 levels were measured using the Human Thrombospondin-1 DuoSet ELISA kit (R&D systems; DY3074) in the supernatant surrounding treated platelets ...
-
bioRxiv - Immunology 2021Quote: ... Antibodies included anti-MMP-9 (AF909; 1:100 R&D Systems); anti IL-1ß (ab9722 ...
-
bioRxiv - Molecular Biology 2021Quote: ... Recombinant human TGFβ1 (100-B-001) and Thrombospondin-1 (3074-TH-050) were purchased from R&D Systems. Matrigel-based hydrogel culture system were employed ...
-
bioRxiv - Neuroscience 2021Quote: ... and goat polyclonal antibodies anti-SOX-9 (1:40; AF3075; R&D Systems) overnight at RT ...
-
bioRxiv - Biochemistry 2020Quote: Phosphorylation of several kinases and expression levels of matrix metallopeptidases (MMPs) were analyzed using Proteome Profiler Human Phospho-Kinase Array Kit (R&D Systems) and Human MMP Antibody Array Kit (Abcam) ...
-
bioRxiv - Cancer Biology 2021Quote: ... Galectin-9 primary antibody (R&D systems, AF-2045) was added to sections at 1 μg/mL dilution and incubated overnight at 4 °C ...
-
bioRxiv - Immunology 2023Quote: ... Siglec-9 blocking antibody (Clone 191240, R&D Systems) was added at a final concentration of 10 µg/mL ...
-
bioRxiv - Immunology 2023Quote: ... Siglec-9 blocking antibody (Clone 191240, R&D Systems) was added at a final concentration of 10 µg/mL ...
-
bioRxiv - Cancer Biology 2022Quote: ... Anti– Siglec-9 antibody (5 μg mL-1; clone 191240, #MAB1139-500, R&D systems, USA) or human IgG isotype control (#31154 ...
-
bioRxiv - Cancer Biology 2020Quote: ... was confirmed by immunohistochemistry on FFPE tissues after antigen retrieval (pH 9) and endogenous peroxidase inhibition followed by overnight incubation with mouse antibody to SBase (anti-SBase; R&D Systems; pH 9; 1:200 dilution). After incubation with primary antibody ...
-
bioRxiv - Cancer Biology 2020Quote: ... was confirmed by immunohistochemistry on FFPE tissues after antigen retrieval (pH 9) and endogenous peroxidase inhibition followed by overnight incubation with mouse antibody to SBase (anti-SBase; R&D Systems; pH 9; 1:200 dilution), followed by incubation with primary antibody ...
-
bioRxiv - Immunology 2023Quote: ... cDC2s were stained in PBA buffer with anti-galectin-9 antibody (1:50, AF2045, R&D systems) and anti-CCR7 (1:200 ...
-
bioRxiv - Bioengineering 2021Quote: ... and FGF-9 (200 ng·ml-1, R&D Systems). By day 7 ...
-
bioRxiv - Neuroscience 2023Quote: ... they were incubated overnight at 4°C with the primary antibody (5mC, Active Motif, cat.no. 39649, lot 02617020, used 1:250; SOX2, R&D Systems, AF2018 ...
-
bioRxiv - Cell Biology 2019Quote: ... coverslips were subsequently incubated with anti-Galectin-9 antibody (AF23045, R&D systems) for 2 h at room temperature ...
-
bioRxiv - Neuroscience 2021Quote: ... Sections were blocked and permeabilized in a permeabilization solution for 2h and incubated in goat polyclonal antibodies against SOX-9 (1:40; AF3075; R&D Systems) and rabbit polyclonal antibodies against GFAP (1:250 ...
-
bioRxiv - Cancer Biology 2022Quote: ... bioreactor media were either left untreated or supplemented with anti– Siglec-9 antibody (5 μg mL-1; clone 191240, #MAB1139-500, R&D systems, USA). On day 5 ...
-
bioRxiv - Microbiology 2021Quote: ... human type I IFN (R&D systems, 11415-1) was typically added at a final concentration of 150 U/ml ...
-
bioRxiv - Cell Biology 2023Quote: ... single cell suspensions were stained with a goat anti-galectin-9 antibody (AF2045, R&D systems) at 40 μg/ml or isotype control as negative control for 30 min at 4 °C ...
-
bioRxiv - Immunology 2023Quote: ... single cell suspensions were stained with a goat anti-galectin-9 antibody (AF2045, R&D systems) at 8 μg/ml or isotype control as negative control for 30 min at 4 °C ...
-
bioRxiv - Microbiology 2023Quote: ... or 1000U/mL universal type 1 interferon (R&D Systems) for 30 minutes ...
-
bioRxiv - Microbiology 2020Quote: ... Recombinant human MMP-9 protein and Recombinant mice MMP-9 protein were purchased from R&D systems. Commercialized DENV2-NS1 protein were purchased from Native Antigen ...
-
bioRxiv - Immunology 2022Quote: ... The functionalized tips were then dipped in different hIL-9 or mIL-9 (both from R&D systems) concentrations ...
-
bioRxiv - Neuroscience 2019Quote: ... MMP-9 (R&D Systems; Minneapolis, MN), IL-6 (Invitrogen Carlsbad ...
-
bioRxiv - Cell Biology 2023Quote: ... The following primary antibodies were used for Western Blotting: goat anti-Galectin-9 (AF2045, R&D systems, Minneapolis, Minnesota) at 1:1000 (v/v) ...
-
bioRxiv - Immunology 2023Quote: ... The following primary antibodies were used for Western Blotting: goat anti-Galectin-9 (AF2045, R&D systems, Minneapolis, Minnesota) at 1:1000 (v/v) ...
-
bioRxiv - Cell Biology 2019Quote: ... goat anti-Galectin-9 (AF2045, R&D systems) at 20 μg/ml ...
-
bioRxiv - Molecular Biology 2023Quote: ... 9 ng/ml Activin A (R&D Systems), 5 ng/ml FGF-2 (R&D Systems ...
-
bioRxiv - Immunology 2024Quote: ... and mouse IL-9 (#DY409, R&D Systems).
-
bioRxiv - Immunology 2022Quote: Llamas were immunized intramuscularly once per week over six weeks with carrier free recombinant human IL-9 or mouse IL-9 (R&D Systems). Each llama (4 in total ...
-
bioRxiv - Cancer Biology 2023Quote: ... Type 2 (R&D Systems) and plated on 8-chamber slides (Thermo Scientific).
-
bioRxiv - Cancer Biology 2023Quote: ... 0.1 million cells (in 100 µL of 1:1 mix of PBS and Cultrex Basement Membrane Extract (Type 3, R&D systems)) were injected into the 4th mammary fat pad of 7-8 weeks old female BALB/c mice ...
-
bioRxiv - Cell Biology 2019Quote: ... goat anti-Galectin-9 (AF2045, R&D systems, Minneapolis, Minnesota) at 1:1000 (v/v ...
-
bioRxiv - Immunology 2020Quote: ... MMP-9 Duoset ELISA was obtained from R&D Systems, Inc ...
-
bioRxiv - Cell Biology 2020Quote: ... [9] and 100ng/ml ActivinA (R&D Systems, 338-AC-050) for 3 days ...
-
bioRxiv - Cell Biology 2021Quote: ... 200 ng/mL FGF9 (fibroblast growth factor 9; R&D Systems), and 1 μg/mL heparin (Sigma-Aldrich)) ...
-
bioRxiv - Bioengineering 2023Quote: ... 200 ng/ml fibroblast growth factor 9 (FGF9; R&D Systems), and 1 μg/ml heparin (Sigma-Aldrich ...
-
bioRxiv - Bioengineering 2023Quote: ... containing 9 ng/mL Activin A (R&D systems, #338-AC), 5 ng/mL BMP4 (R&D systems ...
-
bioRxiv - Cell Biology 2023Quote: ... type 2 (R&D Systems, #3533-001) and cultured and passaged as previously described for Chol-Orgs75 and Hep-Orgs44 ...
-
bioRxiv - Microbiology 2023Quote: ... Uninfected cells were treated with DPBS or 1000U/ml of Universal Type 1 Interferon (R&D Systems) for 30 minutes ...
-
bioRxiv - Cell Biology 2023Quote: ... The remaining volume was divided into two tubes and incubated on ice with either 1 μg of anti-galectin-9 (AF2545, R&D systems) or goat isotype control (Jackson Immunoresearch ...
-
bioRxiv - Cell Biology 2021Quote: ... or MMP-9 at (1,10 & 100 ng/ml) (R&D Systems Europe) in protease buffer (50mM HEPES (pH 7.5 ...
-
bioRxiv - Immunology 2022Quote: ... or caspase-9 inhibitors (50 μM Z-LEHD-FMK, R&D Systems), respectively ...
-
bioRxiv - Immunology 2023Quote: ... moDCs were treated with recombinant galectin-9 protein (AF2045, R&D systems) at a final concentration of 1 µg/ml.
-
bioRxiv - Molecular Biology 2023Quote: ... 9 ng/ml Recombinant Human/Mouse/rat Activin A (R&D Systems) and 5 ng/ml human FGF-2 (Miltenyi Biotec) ...